Eswatini vs Sub-Saharan Africa (IDA & IBRD countries): Antiretroviral therapy coverage for PMTCT
Eswatini
100.0%
in 2024
Sub-Saharan Africa (IDA & IBRD countries)
89.5%
in 2024
Eswatini rank
1st
Sub-Saharan Africa (IDA & IBRD countries) rank
2nd
Antiretroviral therapy coverage for PMTCT over time
- Eswatini
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
Eswatini currently reports 100.0% against 89.5% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 10.5%.
That makes Eswatini's figure about 1.1 times Sub-Saharan Africa (IDA & IBRD countries)'s.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Sub-Saharan Africa (IDA & IBRD countries) ahead.
Eswatini ranks 1st and Sub-Saharan Africa (IDA & IBRD countries) ranks 2nd of 84 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.0% | 20.9% | 11.1% | Eswatini |
| 2010s | 90.4% | 78.2% | 12.2% | Eswatini |
| 2020s | 96.6% | 88.6% | 8.0% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Eswatini or Sub-Saharan Africa (IDA & IBRD countries)?
- Eswatini, at 100.0% against 89.5% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Eswatini and Sub-Saharan Africa (IDA & IBRD countries)?
- 10.5%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Sub-Saharan Africa (IDA & IBRD countries)?
- 25 years are reported by both, from 2000 to 2024.
- How do Eswatini and Sub-Saharan Africa (IDA & IBRD countries) rank globally for antiretroviral therapy coverage for pmtct?
- Eswatini ranks 1st and Sub-Saharan Africa (IDA & IBRD countries) ranks 2nd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).